/PRNewswire/ Necstgen, a non-profit CDMO and ProteoNic, a leading provider of premium vector technology and services for efficient production of biologics,.
LEIDEN, Netherlands, Nov. 1, 2022 /PRNewswire/ ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, today announced the extension
/PRNewswire/ ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, and FyoniBio GmbH, a contract.
LEIDEN, Netherlands, June 15, 2022 /PRNewswire/ ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, today announced licensing
/PRNewswire/ ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, today announced licensing of.